Accessible Search Form           Advanced Search

News & Resources

Press Releases rss feed

July 1, 2014
Adults stop anti-rejection drupgs after parial stem-cell reverses sickle cell disease
Half of patients in a trial have safely stopped immunosuppressant medication following a modified blood stem-cell transplant for severe sickle cell disease, according to a study in the July 1 issue of the Journal of the American Medical Association. The trial was conducted at the National Institutes of Health’s Clinical Center in Bethesda, Maryland, by researchers from NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Heart, Lung, and Blood Institute.

May 19, 2014
Common treatment for patients with chronic, progressive lung disease found to be ineffective
A drug used to treat patients with mild to moderate lung damage from the disease idiopathic pulmonary fibrosis (IPF) is no better than placebo for preserving lung function, according to a study supported by the National Institutes of Health. The finding is in the final report of a clinical trial called Prednisone, Azathioprine, and N-Acetylcysteine: A Study That Evaluates Response in Idiopathic Pulmonary Fibrosis (PANTHER-IPF).

View all press releases


Spotlight On Research

Featured Fact Sheet

Image of Dr. Themistocles L. Assimes

Women’s Health Initiative Data to be Used in New Genomics-Based Studies
In 1993, the NHLBI’s Women's Health Initiative (WHI) began enrolling the first participants in what would become one of the most definitive, far-reaching clinical trials of post-menopausal women's health ever undertaken in the U.S. Read full fact sheet...


NHLBI In The News rss feed

May 21, 2014 : Newswise
GW researcher receives grant to study connection between stress, high blood pressure and the neuroimmune system
Paul Marvar, Ph.D., assistant professor of pharmacology and physiology at the George Washington University School of Medicine and Health Sciences, was awarded a $721,435 grant from the National Heart, Lung, and Blood Institute to study stress-induced hypertension and its effects on the neuroimmune system. This grant will support further understanding of why those with psychological disorders, such as post-traumatic stress disorder (PTSD), have a higher risk of developing high blood pressure.

May 20, 2014 : Forbes
Disappointing results for statins in two NIH trials
Larry Husten
Two NHLBI studies have failed to find any benefit for statin therapy in patients with chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS)

View all NHLBI in the News articles


Upcoming Events

September 17, 2014 - September 18, 2014
NHLBI Annual Sickle Cell Disease Clinical Research Meetings
Bethesda, Maryland

The Annual Sickle Cell Disease Clinical Research Meetings provide a venue for study investigators to meet and review progress in ongoing and proposed clinical trials.


Director's Message
Researcher's Work Helps Awaken Public, Scientific Community to Perils of Bad Sleep

Gary H. Gibbons, M.D.
April 28, 2014

The statistics are startling: 50-70 million U.S. adults have sleep or wakefulness disorders, which account for $50 billion dollars in lost productivity each year. And even those who don’t have a diagnosed disorder often are affected by lack of sleep, asd evidenced by the fact that one-third of Americans get fewer than seven hours of sleep per night....
View full message

View all Director's messages
For the Media
NHLBI Communications Office
nhlbi_news@nhlbi.nih.gov
301-496-4236
Ask for press officer on duty